Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
<p>Harrow (HROW) is a buy at $41.50. The company came into 2026 with reaffirmed revenue guidance, concrete commercial expansion plans, and a high-impact pipeline acquisition. Technical momentum and improving cash generation support an actionable long-term trade while debt and short interest create defined, tradable risk.</p>
Swvl Holdings Corp announced fiscal year 2025 financial results showing a 41% increase in revenue to $24.2 million and a net income of $1.3 million, marking a return to profitability after a $10.3 million loss in 2024. Revenue growth was driven by significant expansion in the Gulf Cooperation Council (GCC) region, with GCC revenues up 122%, alongsi…
WW International, Inc. announced the appointment of Heather Thiltgen, an experienced healthcare executive with expertise in expanding access to GLP-1 therapies and managing complex healthcare markets, to its Board of Directors. This strategic move aims to support the company’s long-term strategy in evolving its integrated weight health offerings am…
Alpha Compute Corp. (NASDAQ: ALP), formerly AlphaTON Capital Corp., has rebranded to reflect its growing specialization in AI GPU-as-a-service and confidential computing infrastructure that caters to privacy-sensitive enterprise workloads. The company leverages NVIDIA Blackwell-generation GPUs to offer sovereign, encrypted AI compute solutions addr…
Biogen Inc. has entered into an agreement to acquire exclusive rights to develop and commercialize felzartamab in the Greater China region from TJ Biopharma. This acquisition consolidates global rights for felzartamab, a promising CD38-directed antibody in Phase 3 trials for multiple immune-related diseases. Biogen will make a $100 million upfront …
Palvella Therapeutics announced that results from its Phase 3 SELVA and Phase 2 TOIVA clinical trials evaluating QTORIN™ 3.9% rapamycin anhydrous gel will be presented at the ISSVA World Congress 2026. These studies demonstrated statistically significant and clinically meaningful improvements in treating microcystic lymphatic malformations and cuta…
BriaCell Therapeutics presented positive Phase 3 clinical data demonstrating preserved quality of life in heavily pretreated metastatic breast cancer patients receiving Bria-IMT combined with immune checkpoint inhibitors, alongside promising Phase 2 biomarker analyses at the 2026 AACR Annual Meeting. These findings support BriaCell's immunotherapy …
Dragonfly Energy announced a material purchase order valued at over $3 million from Stevens Transport for deployment across nearly 500 trucks throughout 2026. This order encompasses Dragonfly's full heavy-duty trucking product portfolio, including lithium-based solutions aimed at reducing engine idling, improving driver comfort, and lowering total …
Barclays downgraded Vale S.A. to "equal weight" from "overweight", arguing the miner's 35% year-to-date share rally has largely eliminated the valuation discount it traded at versus Australian peers. The bank raised its price target modestly to $17 while cutting EPS and EBITDA forecasts, and flagged catalysts concentrated in 2027 including potentia…
Israeli forces have told residents of southern Lebanon to remain out of a continuous strip of territory along the border and to avoid approaching the Litani River, reinforcing a new deployment inside Lebanon even after a U.S.-mediated 10-day ceasefire took effect. The move — shown on maps posted by the Israeli military — seeks to establish a buffer…
New Found Gold Corp. announced a $205 million financing package consisting of a $100 million bought deal equity offering and a $105 million senior secured credit facility with EdgePoint. The funds will finance the initial capital expenditures for the Queensway Gold Project-Phase I, advancing it toward production, as well as general corporate purpos…
Clearmind Medicine Inc., a clinical-stage biotech focused on non-hallucinogenic psychedelic therapeutics, announced positive top-line safety data from its ongoing FDA-approved Phase I/IIa trial of CMND-100, a MEAI-based oral drug candidate targeting Alcohol Use Disorder (AUD). The drug met the primary safety and tolerability endpoint, showing a hig…
During a Mass in Saurimo, Angola, Pope Leo said many people around the world are being "exploited by authoritarians and defrauded by the rich," linking such abuses to a negation of the Christian belief in the resurrection. The remarks form part of a more assertive rhetorical approach on his multi-nation Africa tour, which has included denunciations…
AST SpaceMobile reported that its BlueBird 7 satellite was inserted into an orbit lower than planned after separation on Blue Origin's New Glenn 3 mission, leaving the spacecraft unable to operate and destined to de-orbit. The stock fell 14% on Monday. The company said the spacecraft powered on after separation, that the altitude achieved is insuff…
U.S. companies have expressed notable interest in a range of Democratic Republic of Congo mining assets identified by Kinshasa, including the coltan-rich Rubaya site. A State Department official said any investment in Rubaya must align with U.S.-brokered peace initiatives in eastern Congo. The outreach forms part of a broader U.S. effort to secure …
Deutsche Bank strategist Henry Allen argues that current equity resilience versus the post-Ukraine 2022 selloff reflects meaningful differences in the energy shock environment, inflationary backdrop, central bank pressure and macro trends. Allen highlights four principal factors that make today’s market reaction more durable than the sharp deterior…
TopBuild shares jumped nearly 20% in premarket trading after the company accepted a $17 billion acquisition offer from construction supplies distributor QXO. The unanimous board approvals set up a transaction that will deliver a mix of cash and QXO stock to TopBuild shareholders and create the second-largest publicly traded building products distri…
Gilat Satellite Networks Ltd., a leader in satellite networking technology, announced it will release its first quarter 2026 financial results on May 13, 2026. The company will host conference calls and webcasts in English and Hebrew to discuss the results and business achievements. Gilat's portfolio includes advanced satellite communication soluti…
SummaryPakistan has placed on hold a proposed $1.5 billion sale of weapons and aircraft to Sudan after Saudi Arabia informed Islamabad it would not provide financing and asked that the agreement be terminated. The move follows a March meeting between Sudanese army leaders and Saudi officials in Riyadh in which Saudi financing was withdrawn. The sus…
Marvell Technology's stock climbed sharply in premarket trading after reports that Google is in discussions with the chip designer to build two specialized processors - a memory processing unit to complement Google's tensor processing unit and a new TPU for running AI models. The talks, reported by The Information and attributed to people familiar …
Invivyd, Inc.'s Chairman Marc Elia is a featured speaker at the POLITICO Health Care Summit, discussing the future of viral disease prevention with emphasis on monoclonal antibodies as a next-generation approach beyond vaccines. Invivyd recently received FDA emergency use authorization for a monoclonal antibody treatment, underscoring its role in a…
Pasithea Therapeutics announced that the FDA has granted Rare Pediatric Disease Designation (RPDD) to its drug candidate PAS-004 for the treatment of Neurofibromatosis Type 1 (NF1). This designation supports the drug's potential to address this serious pediatric condition affecting approximately 115,000 individuals in the U.S. PAS-004 already holds…
Radiopharm Theranostics announced encouraging initial findings from the Phase 0/1 HEAT clinical trial evaluating 177Lu-RAD202, a first-in-class HER2-targeted radiopharmaceutical, showing meaningful tumor uptake and a favorable safety profile at the lowest 30 mCi dose. The Data Safety and Monitoring Committee has approved advancing to a higher 130 m…
U.S. Energy Corp. announced the closing of an expanded $20 million senior secured debt facility, together with proceeds from a recent equity offering, expected to complete the Phase 1 capital stack for its Big Sky Carbon Hub. The funding provides financial visibility for Phase 1 construction with commercial operations targeted for Q1 2027. The comp…
TransAlta Corporation announced key leadership changes with Mike Politeski joining as EVP and CFO and Grant Arnold as EVP and Chief Commercial Officer, effective May 2026. These appointments coincide with Joel Hunter ascending to President and CEO, following the retirement of John Kousinioris. The new executives bring extensive experience in financ…
